The role of chemokines in Hodgkin's disease

Julie Teruya-Feldstein, Giovanna Tosato, Elaine S. Jaffe

Research output: Contribution to journalArticlepeer-review

79 Scopus citations


Recent studies have analyzed the expression of chemokines in tissues involved by Hodgkin's disease (HD). The data indicate a significant role for chemokine expression in the pathobiology and pathophysiology of HD. In general, HD tissues showed higher levels of chemokine expression than reactive lymphoid hyperplasia (RLH) tissues. There were major differences in chemokine expression among the different HD subtypes. Similar to previous studies in athymic mice that identified a pattern of chemokine response induced by Epstein-Barr virus (EBV)-infected cells, the expression of IP-10, Mig, RANTES, and MIP1-α was higher in EBV positive compared to EBV negative HD tissues. In addition, there was a direct correlation of eotaxin expression with tissue eosinophilia. By immunohistochemistry, IP-10 and Mig proteins localized in the malignant Reed-Sternberg (RS) cells and their variants, and to some surrounding inflammatory cells. Eotaxin localized to fibroblasts and smooth muscle of blood vessels. In this review, we discuss the patterns of expression of IP-10, Mig, RANTES, MIP1-α, and eotaxin in HD and its subtypes, and the relationship to EBV positivity, LMP1 expression, tissue eosinophilia and T cell infiltration. In addition, we discuss the potential role of chemokines and cytokines in the pathobiology of HD.

Original languageEnglish
Pages (from-to)363-371
Number of pages9
JournalLeukemia and Lymphoma
Issue number3-4
StatePublished - 2000
Externally publishedYes


  • Chemokines
  • Eotaxin
  • Hodgkin's disease
  • IP-10
  • MIP1-α
  • Rantes


Dive into the research topics of 'The role of chemokines in Hodgkin's disease'. Together they form a unique fingerprint.

Cite this